152 related articles for article (PubMed ID: 30952084)
1. Silver(I) complexes with 4,7-phenanthroline efficient in rescuing the zebrafish embryos of lethal Candida albicans infection.
Pavic A; Savić ND; Glišić BĐ; Crochet A; Vojnovic S; Kurutos A; Stanković DM; Fromm KM; Nikodinovic-Runic J; Djuran MI
J Inorg Biochem; 2019 Jun; 195():149-163. PubMed ID: 30952084
[TBL] [Abstract][Full Text] [Related]
2. Mononuclear silver(I) complexes with 1,7-phenanthroline as potent inhibitors of Candida growth.
Savić ND; Vojnovic S; Glišić BĐ; Crochet A; Pavic A; Janjić GV; Pekmezović M; Opsenica IM; Fromm KM; Nikodinovic-Runic J; Djuran MI
Eur J Med Chem; 2018 Aug; 156():760-773. PubMed ID: 30053719
[TBL] [Abstract][Full Text] [Related]
3. New polynuclear 1,5-naphthyridine-silver(I) complexes as potential antimicrobial agents: The key role of the nature of donor coordinated to the metal center.
Đurić S; Vojnovic S; Pavic A; Mojicevic M; Wadepohl H; Savić ND; Popsavin M; Nikodinovic-Runic J; Djuran MI; Glišić BĐ
J Inorg Biochem; 2020 Feb; 203():110872. PubMed ID: 31689592
[TBL] [Abstract][Full Text] [Related]
4. Manganese(II), copper(II) and silver(I) complexes containing 1,10-phenanthroline/1,10-phenanthroline-5,6-dione against
Gandra RM; Pacheco CA; Sangenito LS; Ramos LS; Souza LO; McCarron P; McCann M; Devereux M; Branquinha MH; Santos AL
Future Microbiol; 2024 Mar; 19():385-395. PubMed ID: 38381028
[No Abstract] [Full Text] [Related]
5. Silver(I) complexes with voriconazole as promising anti-Candida agents.
Stanković M; Skaro Bogojevic S; Kljun J; Milanović Ž; Stevanović NL; Lazic J; Vojnovic S; Turel I; Djuran MI; Glišić BĐ
J Inorg Biochem; 2024 Jul; 256():112572. PubMed ID: 38691971
[TBL] [Abstract][Full Text] [Related]
6. Silver(i) complexes with different pyridine-4,5-dicarboxylate ligands as efficient agents for the control of cow mastitis associated pathogens.
Andrejević TP; Milivojevic D; Glišić BĐ; Kljun J; Stevanović NL; Vojnovic S; Medic S; Nikodinovic-Runic J; Turel I; Djuran MI
Dalton Trans; 2020 May; 49(18):6084-6096. PubMed ID: 32319493
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the anti-virulence potential and antifungal efficacy of 5-aminotetrazoles using the zebrafish model of disseminated candidiasis.
Radakovic N; Nikolić A; Jovanović NT; Stojković P; Stankovic N; Šolaja B; Opsenica I; Pavic A
Eur J Med Chem; 2022 Feb; 230():114137. PubMed ID: 35077918
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
de Sá NP; de Paula LFJ; Lopes LFF; Cruz LIB; Matos TTS; Lino CI; de Oliveira RB; de Souza-Fagundes EM; Fuchs BB; Mylonakis E; Johann S
J Glob Antimicrob Resist; 2018 Sep; 14():287-293. PubMed ID: 29715565
[TBL] [Abstract][Full Text] [Related]
9. Mode of anti-fungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes.
Coyle B; Kavanagh K; McCann M; Devereux M; Geraghty M
Biometals; 2003 Jun; 16(2):321-9. PubMed ID: 12572690
[TBL] [Abstract][Full Text] [Related]
10. Silver(I) complexes containing antifungal azoles: significant improvement of the anti-
Stanković M; Kljun J; Stevanović NL; Lazic J; Skaro Bogojevic S; Vojnovic S; Zlatar M; Nikodinovic-Runic J; Turel I; Djuran MI; Glišić BĐ
Dalton Trans; 2024 Jan; 53(5):2218-2230. PubMed ID: 38193719
[TBL] [Abstract][Full Text] [Related]
11. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterisation, and solution behaviour of Ag(I) bis(phenanthroline-oxazine) complexes and the evaluation of their biological activity against the pathogenic yeast Candida albicans.
Evans C; Ahmed M; Beirne DF; McCann M; Kavanagh K; Devereux M; Rooney D; Heaney F
Biometals; 2023 Dec; 36(6):1241-1256. PubMed ID: 37378710
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans Infection Model in Zebrafish (Danio rerio) for Screening Anticandidal Drugs.
Kulatunga DCM; Dananjaya SHS; Nikapitiya C; Kim CH; Lee J; De Zoysa M
Mycopathologia; 2019 Oct; 184(5):559-572. PubMed ID: 31473909
[TBL] [Abstract][Full Text] [Related]
14. Dinuclear silver(i) complexes with a pyridine-based macrocyclic type of ligand as antimicrobial agents against clinically relevant species: the influence of the counteranion on the structure diversification of the complexes.
Savić ND; Petković BB; Vojnovic S; Mojicevic M; Wadepohl H; Olaifa K; Marsili E; Nikodinovic-Runic J; Djuran MI; Glišić BĐ
Dalton Trans; 2020 Aug; 49(31):10880-10894. PubMed ID: 32716429
[TBL] [Abstract][Full Text] [Related]
15. Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to amphotericin B and miconazole.
Eshwika A; Coyle B; Devereux M; McCann M; Kavanagh K
Biometals; 2004 Aug; 17(4):415-22. PubMed ID: 15259362
[TBL] [Abstract][Full Text] [Related]
16. 1,4-Naphthoquinone derivatives potently suppress Candida albicans growth, inhibit formation of hyphae and show no toxicity toward zebrafish embryos.
Janeczko M; Kubiński K; Martyna A; Muzyczka A; Boguszewska-Czubara A; Czernik S; Tokarska-Rodak M; Chwedczuk M; Demchuk OM; Golczyk H; Masłyk M
J Med Microbiol; 2018 Apr; 67(4):598-609. PubMed ID: 29461185
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
[TBL] [Abstract][Full Text] [Related]
18.
Zhao M; Lepak AJ; VanScoy B; Bader JC; Marchillo K; Vanhecker J; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706
[TBL] [Abstract][Full Text] [Related]
19. Clinical isolates of Candida albicans, Candida tropicalis, and Candida krusei have different susceptibilities to Co(II) and Cu(II) complexes of 1,10-phenanthroline.
Hoffman AE; Miles L; Greenfield TJ; Shoen C; DeStefano M; Cynamon M; Doyle RP
Biometals; 2015 Apr; 28(2):415-23. PubMed ID: 25663372
[TBL] [Abstract][Full Text] [Related]
20. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
